UPCC 04624 Prospective reliability study of the Vectrawb360 3D whole body imaging system as a skin cancer screening instrument for solid organ transplant recipients (SOTRs)
Enrolling By Invitation
99 years or below
All
Phase
N/A
147 participants needed
1 Location
Brief description of study
Determine interrater reliability between 3D whole body image assessment and in-person clinical assessment regarding the need for in-person evaluation of keratinocyte carcinomas in high-risk patients.
VectraWB360 3D whole-body photography-based assessment by a dermatologist (Approach 1).
In-person clinical assessment by a dermatologist (Approach 2). Determine interrater reliability between 3D whole body image assessment and in-person clinical assessment of keratinocyte carcinomas in high-risk patients.
VECTRAWB360 3D whole-body photography-based assessment by a dermatologist (Approach 1) and supplementary 2D photographs of scalp, hands, and feet.
In-person clinical assessment by a dermatologist (Approach 2). Determine interrater reliability between 3D whole body image assessment and in-person clinical assessment of keratinocyte carcinomas in high-risk patients by body segment.
Specificity and sensitivity of clinical exam using Vectra images vs in-person clinical exam.
Patient-reported outcomes using Vectra (currently creating the survey questionnaire, we will send it once completed).
Eligibility of study
You may be eligible for this study if you meet the following criteria:
